OR7-005 – Canakinumab in childhood colchicine resistant FMF

por Hashkes, PJ, Aviel, Y Butbul, Lubin, S, Tseng, L, Ben Dayan, E, Rachmilewitz, T, Brik, R
Publicado 2013

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency

por Shinar, Y, Hashkes, PJ, Cohen, R, Kessel, A, Tirosh, I, Padeh, S, Arostegui, J, Livneh, A
Publicado en Pediatr Rheumatol Online J (2015)

Differentiation of post streptococcal reactive arthritis from acute rheumatic fever

por Barash, J, Mashihach, E, Navon-Elkan, P, Berkun, Y, Harel, L, Tauber, T, Padeh, S, Hashkes, PJ, Uziel, Y
Publicado 2008

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial

por Hashkes, PJ, Spalding, SJ, Giannini, EH, Huang, B, Park, G, Barron, KS, Weisman, MH, Pashinian, N, Reiff, AO, Samuels, J, Wright, D, Kastner, DL, Lovell, DJ
Publicado 2011

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)

por Levy-Lahad, E, Elkan-Navon, P, Segel, R, Pierce, SB, Walsh, T, Barash, J, Padeh, S, Zlotogorski, A, Berkun, YY, Press, JJ, Mukamel, M, Hashkes, PJ, Harel, LL, Tekin, M, Yalcinkaya, F, Kasapcopur, O, Emirogullari, EF, Lee, MK, Klevit, RE, Renbaum, PF, Weinberg-Shukron, A, Zeligson, S, Marek-Yagel, D, Shohat, M, Singer, A, Pras, E, Rubinow, AA, Anikster, Y, King, M-C
Publicado 2013